Skip to content

Homoeopathic treatment of Anal fissure

Uility of Individualized Homoeopathic Medicine in 50-millesimal potencies in the management of Anal Fissure: A Pretest-Posttest Interventional Trial - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077014
Enrollment
50
Registered
2024-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K602- Anal fissure, unspecified

Interventions

Intervention1: Individualized Homoeopathic medicine.: Individualized homoeopathic medicine is known and safe for use. The medicines will be administered orally. Medicines will be selected as per the s

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Age:18 - 65 years. ii. Gender: Both Male and Female. iii. Diagnosed cases of Anal Fissure iv. Patients using topical agents for fissure will be included after a washout period of two weeks, subject to persistence of symptoms and signs of fissures v. Patient voluntarily giving written informed consent for the study.

Exclusion criteria

Exclusion criteria: i. Severe co-morbidities or any other uncontrolled systemic diseases, life-threatening illness etc. affecting Quality of Life. ii. Pregnant or breast-feeding women. iii. Substance abuse and/ or dependence. iv. Psychologically unstable patients. v. Previous history of surgical interventions for anal fissure. vi. Diagnosed or any suspected cases of rectal malignancies vii. Under-going homoeopathic treatment for any chronic diseases for last 3 months. viii. Patients who are unable to read the patient information sheet and written consent form. ix. Patient unwilling to take part in the study and not giving written consent for this study.

Design outcomes

Primary

MeasureTime frame
Numerical pain rating scale (0-10).Timepoint: Baseline and after 3 months.

Secondary

MeasureTime frame
HEMO-FISS scaleTimepoint: Baseline and after 3 months.;Modified Naranjo Criteria for Homoeopathy (MONARCH)Timepoint: After 3 months of treatment

Countries

India

Contacts

Public ContactDr Rajib Purkait

National Institute of Homoeopathy

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026